Sun, 05 Sep 2010 10:02:33 GMT

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ has long been an area of discussion and confusion for patients and physicians alike.

Tue, 10 Aug 2010 09:27:40 GMT

Cancer Research UK scientists have discovered that a gene called POLQ is linked to an eight-fold risk of breast cancer returning.

Wed, 14 Jul 2010 10:07:43 GMT

Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of ...